-
公开(公告)号:EP1069897A1
公开(公告)日:2001-01-24
申请号:EP99916334.8
申请日:1999-04-07
Applicant: ELI LILLY AND COMPANY
Inventor: GRUBER, Joseph, Michael , NORMAN, Bryan, H.
IPC: A61K31/44 , C07D498/02
CPC classification number: C07D498/04 , A61K31/4745
Abstract: The present invention relates to a compound of formula (I) which is useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
-
公开(公告)号:EP1067932A1
公开(公告)日:2001-01-17
申请号:EP99917359.4
申请日:1999-04-07
Applicant: ELI LILLY AND COMPANY
Inventor: GRUBER, Joseph, Michael , HOLLINSHEAD, Sean, Patrick , NORMAN, Bryan, Hurst , WILSON, Joseph, Wendell
IPC: A61K31/47 , C07D498/04
CPC classification number: C07D498/04
Abstract: The present invention relates to a compound of formula (I) which is useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
Abstract translation: 本发明涉及式(I)化合物,其可用于抑制MRP1部分或全部赋予抗性的抗性肿瘤。
-
公开(公告)号:EP1250340B1
公开(公告)日:2004-11-17
申请号:EP00986242.6
申请日:2000-12-11
Applicant: ELI LILLY AND COMPANY
Inventor: BONJOUKLIAN, Rosanne , COHEN, Jeffrey, Daniel , GRUBER, Joseph, Michael , JOHNSON, Douglas, Webb , JUNGHEIM, Louis, Nickolaus , KROIN, Julian, Stanley , LANDER, Peter, Ambrose , LIN, Ho-Shen , LOHMAN, Mark, Christopher , MUEHL, Brian, Stephen , NORMAN, Bryan, Hurst , PATEL, Vinod, Francis , RICHETT, Michael, Enrico , THRASHER, Kenneth, Jeff , VEPACHEDU, Sreenivasarao , WHITE, Wesley, Todd , XIE, Yongping , YORK, Jeremy Schulenburg , PARKHURST, Brandon, Lee , WANG, Quiping
IPC: C07D498/04 , A61K31/47 , A61P35/00 , A61P43/00
CPC classification number: C07D471/04
Abstract: The present invention further relates to a method of inhibiting MRP1 in a mammal which comprises administering to a mammal in need thereof an effective amount of a compound of formula (I).
-
公开(公告)号:EP1067928A1
公开(公告)日:2001-01-17
申请号:EP99916456.9
申请日:1999-04-07
Applicant: ELI LILLY AND COMPANY
IPC: A61K31/44 , C07D498/02
CPC classification number: A61K31/704 , A61K31/475 , A61K45/06 , C07D498/02 , A61K2300/00
Abstract: The present invention relates to a compound of formula (I), which is useful for inhibiting resistant neoplasms where the resistance is conferred in part or in total by MRP1.
-
公开(公告)号:EP1250340A1
公开(公告)日:2002-10-23
申请号:EP00986242.6
申请日:2000-12-11
Applicant: ELI LILLY AND COMPANY , Wang, Qiuping
Inventor: BONJOUKLIAN, Rosanne , COHEN, Jeffrey, Daniel , GRUBER, Joseph, Michael , JOHNSON, Douglas, Webb , JUNGHEIM, Louis, Nickolaus , KROIN, Julian, Stanley , LANDER, Peter, Ambrose , LIN, Ho-Shen , LOHMAN, Mark, Christopher , MUEHL, Brian, Stephen , NORMAN, Bryan, Hurst , PATEL, Vinod, Francis , RICHETT, Michael, Enrico , THRASHER, Kenneth, Jeff , VEPACHEDU, Sreenivasarao , WHITE, Wesley, Todd , XIE, Yongping , YORK, Jeremy Schulenburg , PARKHURST, Brandon, Lee , WANG, Quiping
IPC: C07D498/04 , A61K31/47 , A61P35/00 , A61P43/00
CPC classification number: C07D471/04
Abstract: The present invention further relates to a method of inhibiting MRP1 in a mammal which comprises administering to a mammal in need thereof an effective amount of a compound of formula (I).
-
公开(公告)号:EP1077701A1
公开(公告)日:2001-02-28
申请号:EP98923565.0
申请日:1998-05-20
Applicant: ELI LILLY AND COMPANY
Inventor: EZQUERRA-CARRERA, Jesus , GRUBER, Joseph, Michael , HAMDOUCHI, Chafiq, Hamdouchi , HOLMES, Richard, Elmer , SPITZER, Wayne, Alfred
IPC: A61K31/44 , C07D471/04
CPC classification number: C07D471/04
Abstract: The present invention relates to compounds of Formula (I), which inhibit the growth of picornaviruses, Hepatitus viruses, enteroviruses, cardioviruses, polioviruses, coxsackieviruses of the A and B groups, echo virus and Mengo virus. In said Formula, A is phenyl, pyridyl, substituted phenyl, substituted pyridyl, or benzyl; R is hydrogen, COR4, or COCF¿3?; X is N-OH, O, or CHR?1; R1¿ is hydrogen, halo, CN, C¿1?-C4 alkyl, -C CH, CO(C1-C4 alkyl), CO2(C1-C4 alkyl), or CONR?2R3; R2 and R3¿ are independently hydrogen or C¿1?-C4 alkyl; A' is hydrogen, halo, C1-C6 alkyl, benzyl, naphthyl, thienyl, furyl, pyridyl, pyrollyl, COR?4¿, S(O)¿nR?4, or a group of formula (II); R4 is C1-C6 alkyl, phenyl, or substituted phenyl; n is 0, 1, or 2; R5 is independently at each occurance hydrogen or halo; m is 1, 2, 3, or 4; and R6 is hydrogen, halo, CF¿3?, OH, CO2H, NH2, NO2, CONHOCH3, C1-C4 alkyl, or CO2(C1-C4 alkyl), C1-C4 alkoxy; or pharmaceutically acceptable salts thereof.
-
-
-
-
-